Prostate cancer: open trials in Netherlands

67 open trials have a site in Netherlands. Registry data; only the trial team decides who can take part.

NCT06136624
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Meander Medisch Centrum Stichting, Amersfoort · Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting, Amsterdam · Stichting Amsterdam UMC, Amsterdam · Zuyderland Medisch Centrum Stichting, Heerlen · Spaarne Gasthuis Stichting, Hoofddorp · Medisch Centrum Leeuwarden B.V., Leeuwarden · Stichting Radboud University Medical Center, Nijmegen · Sint Franciscus Vlietland Groep Stichting, Rotterdam · Haga Hospital, 's-Gravenhage · St. Elisabeth Hospital Tilburg, Tilburg · Stichting Viecuri Medisch Centrum voor Noord-Limburg, Venlo
Registry updated 2026-11-05
NCT06122584
Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer
Trial Treatment · Phase 3 · ABX advanced biochemical compounds GmbH
Radboud UMC, Nijmegen · CWZ, Nijmegen
Registry updated 2026-11-04
2026-526983-19-00
A clinical trial of MK-1568 in participants with prostate cancer (MK-1568-001)
Trial Treatment · Phase 1 · Merck Sharp & Dohme LLC
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting, Amsterdam · Radboud universitair medisch centrum Stichting, Nijmegen
Registry updated 2026-11-03
NCT06095089
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam
Registry updated 2026-11-03
NCT07164443
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Reinier de Graaf Groep, Delft · Stichting Martini Ziekenhuis, Groningen · Tergooiziekenhuizen, Hilversum · Spaarne Gasthuis Stichting, Hoofddorp · Academisch Ziekenhuis Maastricht, Maastricht · Canisius Wilhelmina Ziekenhuis, Nijmegen · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Isala Klinieken Stichting, Zwolle
Registry updated 2026-11-03
NCT06629779
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Trial Treatment · Phase 3 · Pfizer
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting, Amsterdam · Frisius MC, Leeuwarden · Canisius Wilhelmina Ziekenhuis, Nijmegen · Sint Franciscus Vlietland Groep Stichting, Schiedam
Registry updated 2026-10-30
NCT06925737
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Ziekenhuisgroep Twente Stichting, Almelo · Meander Medisch Centrum, Amersfoort · Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting, Amsterdam · Stichting Martini Ziekenhuis, Groningen · Tergooiziekenhuizen, Hilversum · Spaarne Gasthuis Stichting, Hoofddorp · Academisch Ziekenhuis Maastricht, Maastricht · Sint Antonius Ziekenhuis Stichting, Nieuwegein · Radboud universitair medisch centrum Stichting, Nijmegen · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Sint Franciscus Vlietland Groep Stichting, Rotterdam · Haga Hospital, 's-Gravenhage · Stichting Viecuri Medisch Centrum voor Noord-Limburg, Venlo
Registry updated 2026-10-30
NCT07332455
First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
Trial Treatment · Phase 1/2 · GlaxoSmithKline
Amsterdam · Nijmegen
Registry updated 2026-10-28
NCT07529418
The BALANCE Study: BlAck and Mixed Men's Lived Experience With Prostate cANCEr-Diversity in Prostate Cancer PROMS Study
Research · Institute of Cancer Research, United Kingdom
The Erasmus MC, Rotterdam
Registry updated 2026-10-27
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 2 · Daiichi Sankyo
Amsterdam UMC Locatie VUMC, Amsterdam · Universitair Medisch Centrum Groningen, Groningen · Leids Universitair Medisch Centrum, Leiden · Maastricht University Medical Center, Maastricht · Radboud University Medical Center, Nijmegen
Registry updated 2026-10-26
NCT05939414
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting, Amsterdam
Registry updated 2026-10-21
NCT06279130
Pan-tumor neoadjuvant basket study of immune check-point inhibition and novel IO combinations (NEOASIS)
Trial Treatment · Phase 2 · Netherlands Cancer Institute
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting, Amsterdam
Registry updated 2026-10-21
NCT07213674
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Trial Treatment · Phase 3 · Amgen
Universitair Medisch Centrum Groningen, Groningen
Registry updated 2026-10-20
NCT07611110
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Trial Treatment · Phase 3 · AstraZeneca
Amsterdam · Nijmegen
Registry updated 2026-10-19
NCT06952803
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Trial Treatment · Phase 3 · AstraZeneca
Tergooiziekenhuizen, Hilversum · Academisch Ziekenhuis Maastricht, Maastricht · Canisius Wilhelmina Ziekenhuis, Nijmegen · Bravis Ziekenhuis, Roosendaal
Registry updated 2026-10-14
NCT07028853
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Trial Treatment · Phase 3 · Pfizer
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting, Amsterdam · Reinier de Graaf Groep, Delft · Tergooiziekenhuizen, Hilversum · Canisius Wilhelmina Ziekenhuis, Nijmegen
Registry updated 2026-10-14
NCT06863272
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Ziekenhuis Nij Smellinghe, Drachten · Ziekenhuis Gelderse Vallei Stichting, Ede Gld · Radboud universitair medisch centrum Stichting, Nijmegen
Registry updated 2026-10-09
2025-520555-89-00
Phase 3 Study of Xaluritamig Plus Abiraterone vs Investigator's Choice in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Trial Treatment · Phase 3 · Amgen Inc.
Universitair Medisch Centrum Groningen, Groningen
Registry updated 2026-09-17
NCT06970275
To Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery.
Research · XEOS Medical
UMCG, Groningen
Registry updated 2026-09-15
NCT05762536
Docetaxel or Cabazitaxel With or Without Darolutamide in mCRPC
Trial Treatment · Phase 2 · Erasmus Medical Center
Erasmus MC Cancer Institute, Rotterdam
Registry updated 2026-09-10
NCT07560748
Prospective Prostate Cancer Infrastructure
Research · Radboud University Medical Center
Radboud University Medical Center, Nijmegen
Registry updated 2026-09-10
2023-504026-19-01
[18F]PSMA-1007 PET CT in patients with newly-diagnosed prostate cancer
Trial Treatment · Phase 3 · Abx Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GmbH
Stichting Radboud University Medical Center, Nijmegen · Canisius-Wilhelmina Hospital, Nijmegen
Registry updated 2026-09-04
NCT07192614
A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer
Trial Treatment · Phase 1/2 · AstraZeneca
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting, Amsterdam · Academisch Ziekenhuis Maastricht, Maastricht
Registry updated 2026-09-02
NCT07782164
Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study)
Research · Amsterdam UMC, location VUmc
Amsterdam UMC, Amsterdam
Registry updated 2026-08-28
NCT06024772
Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer
Trial Treatment · Phase 3 · Thomas Jefferson University
Amsterdam Medical Center, Amsterdam-Zuidoost
Registry updated 2026-08-25

All Prostate cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error